That's because the breakdown of cartilage in the shoulder—a result of shoulder pain pump use—often requires additional invasive surgery and, in some cases a total shoulder replacement that can cost much more than most can afford to pay.
Lawsuits have sprung up due to the allegation that various shoulder pain pump manufacturers lobbied the US Food and Drug Administration (FDA) to approve the use of pain pump insertion into the shoulder. When the FDA refused, manufacturers allegedly went ahead and promoted the use of the shoulder pain pump directly to the shoulder joint to doctors, without the FDA's blessing.
The shoulder pain pump is approved for use in soft tissue surrounding the shoulder joint, but not directly to the shoulder, out of concern for the welfare of shoulder joint cartilage. Certain combinations of pain medication have proven toxic to cartilage. Once the cartilage breaks down, a painful condition known as Chondrolysis develops with often devastating consequences.
Critics Say Shoulder Pain Pump Manufactures Must Shoulder Their Part of the Blame
READ MORE SHOULDER PAIN PUMP LEGAL NEWS
As a result Ms. Ashcroft suffered narrowing of the joint space and/or chondrolysis, a condition, which results in the complete, or near-complete loss of cartilage in the shoulder joint. Chondrolysis is irreversible, save for replacing the entire shoulder. Her lawsuit alleges that defendant I-Flow did not warn the plaintiff or her surgeon, who used the devices as instructed and directed by the defendant, about the unreasonable risks and dangers of using the pain pump and anesthetic medications in such fashio